Interestingly, 2 patients in our cohort with an initial suspicion of spindle cell malignancy, given the identification of CTNNB1 mutation, were subsequently diagnosed with a benign tumor, and appropriately enrolled under active surveillance, possibly avoiding unnecessary chemotherapy-related toxicity. This evidence concerns the gene CTNNB1 and benign neoplasm.